PROCEPT BioRobotics Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PRCT | BBNX | BVS | 2252.HK | ATEC | MBOT | |
|---|---|---|---|---|---|---|
| Market cap | 1.23B | 921.52M | 781.98M | 21.84B | 1.27B | 76.57M |
| P/E (TTM) | — | — | 14.1 | — | — | — |
| Forward P/E | -18.5 | -7.8 | 12.5 | 70.6 | 14.7 | -3.6 |
| Price/book | 3.3 | 2.3 | 3.3 | 45.3 | -552.0 | 1.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −30.80% | −43.04% | +52.67% | −16.55% | −62.12% | −48.58% |
| Today | +7.39% | +12.25% | +4.34% | 0.00% | +10.84% | +4.59% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All PRCT news ›Transcript : PROCEPT BioRobotics Corporation, Q2 2026 Earnings Call, Aug 04, 2026
Presentation Operator MessageOperator Good day, and thank you for standing by. Welcome to Q2 2026 PROCEPT BioRobotics Earnings Conference Call. [Operator Instructions] Please be advised that Transcript : PROCEPT BioRobotics Corporation, Q2…
PROCEPT BioRobotics Corporation Provides Earnings Guidance for the Full Year Ending December 31, 2026
PROCEPT BioRobotics Corporation provided earnings guidance for the full year ending December 31, 2026. For the year, Company reiterates revenue to be in the range of $390 million to $410 million,... Published on 08/04/2026 at 04:05 pm EDT…
PROCEPT BioRobotics Corporation Announces Appointment of Dr. Michael Mack as Member of the Board, Effective October 2, 2026
PROCEPT BioRobotics Corporation appointed Dr. Michael Mack as a new member of the Board to fill the resulting vacancy, effective October 2, 2026. Dr. Mack was classified as a Class II director, and... PROCEPT BioRobotics Corporation…
Leerink Partners Sticks to Their Hold Rating for PROCEPT BioRobotics (PRCT)
Leerink Partners analyst Mike Kratky maintained a Hold rating on PROCEPT BioRobotics today and set a price target of $20.00. According to TipRanks, Kratky is a 4-star analyst with an average return of 12.9% and a 45.86% success rate.…
Procept BioRobotics initiated with an Overweight at Barclays
Barclays analyst Christopher Pasquale initiated coverage of Procept BioRobotics (PRCT) with an Overweight rating and $30 price target The firm ... Procept BioRobotics initiated with an Overweight at Barclays Barclays analyst Christopher…
Analysts Are Bullish on Top Healthcare Stocks: Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), PROCEPT BioRobotics (PRCT) and Taysha Gene Therapies (TSHA) with bullish sentiments. TD Cowen analyst Josh Jennings…
Comparing Coloplast A/S (OTCMKTS:CLPBY) and PROCEPT BioRobotics (NASDAQ:PRCT)
Posted by Danessa Lincoln on Oct 28th, 2026 PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) and Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two…
PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
/PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between... NEW YORK, Aug. 26, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor…
PROCEPT BioRobotics: Compelling Bet On Aquablation's Growth
PROCEPT BioRobotics’ Aquablation may ease BPH symptoms while preserving function. Read here for a detailed investment analysis of PRCT stock. - PROCEPT BioRobotics offers Aquablation to help with symptom relief while preserving sexual and…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com9
- globenewswire.com4
- markets.businessinsider.com4
- stocktitan.net4
- themarketsdaily.com3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 40 articles, not a forecast.